CHEK2 1100delC Variant and Breast Cancer Risk in Caucasians: A Meta-analysis Based on 25 Studies with 29,154 Cases and 37,064 Controls |
Yang, Yuan
(Department of Cardiology, the First Affiliated Hospital, Chongqing Medical University)
Zhang, Fan (School of Public Health and Health Management, Chongqing Medical University) Wang, Yang (School of Public Health and Health Management, Chongqing Medical University) Liu, Sheng-Chun (Department of Endocrine and Breast Surgery, the First Affiliated Hospital, Chongqing Medical University) |
1 | Baeyens A, Claes K, Willems P, et al (2005). Chromosomal radiosensitivity of breast cancer with a CHEK2 mutation. Cancer Genet Cytogenet, 163, 106-12. DOI |
2 | Baig RM, Mahjabeen I, Sabir M, et al (2011). Genetic changes in the PTEN gene and their association with breast cancer in Pakistan. Asian Pac J Cancer Prev, 12, 2773-8. |
3 | Bell DW, Kim SH, Godwin AK, et al (2007). Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. Int J Cancer, 121, 2661-7. DOI |
4 | Bell DW, Varley JM, Szydlo TE, et al (1999). Heterozygous germ line hCHEK2 mutations in Li-Fraumeni syndrome. Science, 286, 2528-31. DOI ScienceOn |
5 | Bernstein JL, Teraoka SN, John EM, et al (2006). The allelic variant and risk of breast cancer: Screening results from the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev, 15, 348-52. DOI |
6 | CHEK2 Breast Cancer Consortium (2004). and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer patient cases and 9,065 controls from 10 studies. Am J Hum Genet, 74, 1175-82. DOI |
7 | Chen S, Parmigiani G (2007). Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol, 25, 1329-33. DOI ScienceOn |
8 | Dufault MR, Betz B, Wappenschmidt B, et al (2004). Limited relevance of the CHEK2 gene in hereditary breast cancer. Int J Cancer, 110, 320-5. DOI |
9 | Choi DH, Cho DY, Lee MH, et al (2008). The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation. Breast Cancer Res Treat, 112, 569-73. DOI |
10 | Cybulski C, Wokołorczyk D, Huzarski T, et al (2007). A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland. Breast Cancer Res Treat, 102, 119-22. DOI |
11 | Einarsdottir K, Humphreys K, Bonnard C, et al (2006). Linkage disequilibrium mapping of CHEK2: Common variation and breast cancer risk. PLoS Med, 3, e168. DOI |
12 | Fletcher O, Johnson N, Dos Santos Silva I, et al (2009). Family History, Genetic Testing, and Clinical Risk Prediction: Pooled Analysis of in 1,828 Bilateral Breast Cancers and 7,030 Controls. Cancer Epidemiol Biomarkers Prev, 18, 230-4. DOI |
13 | Friedrichsen DM, Malone KE, Doody DR, et al (2004). Frequency of CHEK2 mutations in a population based, patient case-control study of breast cancer in young women. Breast Cancer Res, 6, R629-35. DOI |
14 | Mateus Pereira LH, Sigurdson AJ, Doody MM, et al (2004). CHEK2:1100delC and female breast cancer in the United States. Int J Cancer, 112, 541-3. DOI |
15 | Iniesta MD, Gorin MA, Chien LC, et al (2010). Absence of mutation in families with hereditary breast cancer in North America. Cancer Genet Cytogenet, 202, 136-40. DOI |
16 | Kleibl Z, Novotny J, Bezdickova D, et al (2005). The CHEK2 c. 1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic. Breast Cancer Res Treat, 90, 165-7. DOI |
17 | Lee AS, Ang P (2008). screening of Asian women with a family history of breast cancer is unwarranted. J Clin Oncol, 26, 2419 (author reply 2419-20). |
18 | McInerney NM, Miller N, Rowan A, et al (2010). Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort. Breast Cancer Res Treat, 121, 203-10. DOI |
19 | Miki Y, Swensen J, Shattuck-Eidens D, et al (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71. DOI |
20 | Meijers-Heijboer H, van den Ouweland A, Klijn J, et al (2002). Low-penetrance susceptibility to breast cancer due to in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet, 31, 55-9. DOI |
21 | Offit K, Pierce H, Kirchhoff T, et al (2003). Frequency of in New York breast cancer cases and controls. BMC Med Genet, 4, 1. |
22 | Overton, Randall C (1998). A comparison of fixed-effects and mixed (random-effects) models for meta-analysis tests of moderator variable effects. Psychological Methods, 3, 354-79. DOI |
23 | Rajkumar T, Soumittra N, Nancy NK, et al (2003). BRCA1, BRCA2 and CHEK2 (1100 del C) germline mutations in hereditary breast and ovarian cancer families in South India. Asian Pac J Cancer Prev, 4, 203-8. |
24 | Song CG, Hu Z, Yuan WT, et al (2006). CHEK2 c. 1100delC may not contribute to genetic background of hereditary breast cancer from Shanghai of China. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 23, 443-5. (In Chinese) |
25 | Rashid MU, Jakubowska A, Justenhoven C, et al (2005). German populations with infrequent and minor associations with early-onset and familial breast cancer. Eur J Cancer, 41, 2896-903. DOI |
26 | Shih HA, Couch FJ, Nathanson KL, et al (2002). BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic. J Clin Oncol, 20, 994-9. DOI |
27 | Sodha N, Bullock S, Taylor R, et al (2002). CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours. Br J Cancer, 87, 1445-8. DOI ScienceOn |
28 | Thirthagiri E, Cheong LS, Yip CH, et al (2009). does not contribute to risk to breast cancer among Malay, Chinese and Indians in Malaysia. Fam Cancer, 8, 355-8. DOI |
29 | Vahteristo P, Bartkova J, Eerola H, et al (2002). A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet, 71, 432-8. DOI |
30 | Weischer M, Bojesen SE, Ellervik C, et al (2008). Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26,000 Patient Cases and 27,000 Controls. J Clin Oncol, 26, 542-8. DOI |
31 | Weischer M, Bojesen SE, Tybjaerg-Hansen A, et al (2007). Increased risk of breast cancer associated with . J Clin Oncol, 25, 57-63. |
32 | Zhang S, Phelan CM, Zhang P, et al (2008). Frequency of the CHEK2 1100delC Mutation among Women with Breast Cancer: An International Study. Cancer Res, 68, 2154-7. DOI |
33 | Wooster R, Bignell G, Lancaster J, et al (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature, 378, 789-92. DOI ScienceOn |
34 | World Cancer Report (2008). International Agency for Research on Cancer. Available at: http://globocan.iarc.fr/factsheets/populations/factsheet.asp?uno=900. |
35 | Zhang B, Beeghly-Fadiel A, Long J, and Zheng W (2011). Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol, 12, 477-88. DOI |